Role of Biomarkers to Assess the Use of Alcohol

J Clin Gastroenterol. 2023 Jul 1;57(6):537-545. doi: 10.1097/MCG.0000000000001852.


Alcohol-associated liver disease has seen a significant rise in the last 2 decades, with an associated rise in the need for accurate alcohol use assessment. Alcohol use has been associated with poor outcomes in both the pre-liver transplant and post-liver transplant patients. Patients with alcohol use disorder often under-report their alcohol consumption because of varying factors, highlighting the need for objective assessment of alcohol use. Aside from the available self-report questionnaires, multiple serologic biomarkers are currently available to assist clinicians to assess recent alcohol consumption among patients with chronic liver disease, liver transplant candidates, and recipients. In this review, we will assess some of these alcohol biomarkers, discuss their strengths and weakness, and review-available data to discuss their role in pre-liver transplant and post-liver transplant population.

Publication types

  • Review

MeSH terms

  • Alcohol Drinking / adverse effects
  • Biomarkers
  • Ethanol
  • Humans
  • Liver Diseases, Alcoholic* / diagnosis
  • Liver Transplantation*


  • Ethanol
  • Biomarkers